NIXON PEABODY TRUST CO Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001626757
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 175 positions · Total reported value $1.41B · Top-10 concentration 44.0% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 31.8% · 23 new · 33 cut · 7 exited
Active Share (vs S&P 500): 53.7% · vs QQQ: 64.9% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2026 13F filing, NIXON PEABODY TRUST CO disclosed 175 equity positions with a combined reported value of $1.41B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.0% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q2 2026 were IDEV ($98.53M), AVLV ($93.47M), NVDA ($70.56M). By sector, the heaviest allocations are Technology 32.8%, Consumer Discretionary 11.8%. Versus the prior quarter, allocation shifted toward Technology (+1.2pp), Other (+0.8pp) and away from Financials (-0.5pp), Energy (-0.7pp).
Versus the prior quarter, NIXON PEABODY TRUST CO opened 23 new positions, trimmed 33 and fully exited 7, a turnover rate of 31.8% of positions. The portfolio's overlap with the prior quarter was 82% of names.
The largest new positions opened in Q2 2026 were ANET ($10.12M), AZN ($8.00M), UL ($6.74M).
Of the 7 positions fully exited versus the prior quarter, the largest were MBB ($902.69K), IEFA ($404.04K), USIG ($258.51K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
- ANET ARISTA NETWORKS INC · $10.12M
- AZN ASTRAZENECA PLC · $8.00M
- UL Unilever PLC Sp ADR New · $6.74M
- XYL XYLEM INC · $2.28M
- VIG VANGUARD SPECIALIZED FUNDS · $964.46K
- SCHD SCHWAB STRATEGIC TR · $787.77K
- VGNT VERSIGENT PLC · $640.65K
- VWO VANGUARD INTL EQUITY INDEX F · $589.86K
Fully Exited (vs previous quarter)
- MBB ISHARES TR · prev qtr: $902.69K
- IEFA ISHARES TR · prev qtr: $404.04K
- USIG ISHARES TR · prev qtr: $258.51K
- CME CME GROUP INC · prev qtr: $251.05K
- SWZ TOTAL RETURN SECURITIES FUND · prev qtr: $249.20K
- COP CONOCOPHILLIPS · prev qtr: $216.61K
- T AT&T INC · prev qtr: $209.66K
- RNXT RENOVORX INC · prev qtr: $98.14K
Insider Transactions (Form 4)
Latest NIXON PEABODY TRUST CO buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Nixon Peabody is an SEC-registered 13F filer. As of Q2 2026 it reported 175 US equity positions with a combined value of $1.41B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 175 positions · $1.41B reported value (Q2 2026)
- Top 10 holdings = 44.0% of reported value
- Largest position: IDEV (ISHARES TR) at 7.0%
- Average position size: $8.08M
Sector Tilt
- Information Technology 32.8%
- Consumer Discretionary 11.8%
- Financials 7.1%
- (classified holdings cover 70% of value)
Quarterly Activity
- Q2 2026: 24 new, 64 added, 55 reduced, 9 exited
- 32 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.11M | $98.53M | 6.97% | Add | |
| 2 |
|
1.02M | $93.47M | 6.61% | Reduce | |
| 3 |
|
352.62K | $70.56M | 4.99% | Add | |
| 4 |
|
240.52K | $69.60M | 4.92% | Reduce | |
| 5 |
|
75.12K | $56.26M | 3.98% | Add | |
| 6 |
|
149.33K | $55.70M | 3.94% | Reduce | |
| 7 |
|
131.84K | $53.99M | 3.82% | Hold | |
| 8 |
|
131.06K | $46.31M | 3.28% | Add | |
| 9 |
|
177.00K | $42.19M | 2.98% | Reduce | |
| 10 |
|
94.24K | $35.60M | 2.52% | Hold | |
| 11 |
|
100.26K | $34.19M | 2.42% | Reduce | |
| 12 |
|
90.42K | $32.31M | 2.29% | Reduce | |
| 13 |
|
80.18K | $26.25M | 1.86% | Hold | |
| 14 |
|
299.20K | $24.57M | 1.74% | Add | |
| 15 |
|
11.60K | $23.07M | 1.63% | Reduce | |
| 16 |
|
39.33K | $22.15M | 1.57% | Add | |
| 17 |
|
102.14K | $21.35M | 1.51% | Reduce | |
| 18 |
|
16.30K | $19.55M | 1.38% | Reduce | |
| 19 |
|
37.87K | $19.45M | 1.38% | Reduce | |
| 20 |
|
118.55K | $17.96M | 1.27% | Reduce | |
| 21 |
|
47.76K | $16.93M | 1.20% | Add | |
| 22 |
|
56.92K | $16.47M | 1.17% | Reduce | |
| 23 |
|
83.49K | $14.88M | 1.05% | Add | |
| 24 |
|
73.21K | $14.15M | 1.00% | Add | |
| 25 |
|
171.33K | $13.92M | 0.98% | Reduce | |
| 26 |
|
241.48K | $13.76M | 0.97% | Reduce | |
| 27 |
|
92.56K | $13.57M | 0.96% | Reduce | |
| 28 |
|
18.83K | $13.56M | 0.96% | Reduce | |
| 29 |
|
136.12K | $13.51M | 0.96% | Add | |
| 30 |
|
21.00K | $13.32M | 0.94% | Reduce | |
| 31 |
|
42.08K | $13.25M | 0.94% | Add | |
| 32 |
|
17.40K | $13.00M | 0.92% | Reduce | |
| 33 |
|
113.57K | $12.86M | 0.91% | Reduce | |
| 34 |
|
37.80K | $12.65M | 0.90% | Reduce | |
| 35 |
|
417.07K | $11.84M | 0.84% | Add | |
| 36 |
|
27.43K | $11.69M | 0.83% | Add | |
| 37 |
|
69.44K | $11.57M | 0.82% | Reduce | |
| 38 |
|
148.78K | $11.54M | 0.82% | Add | |
| 39 |
|
58.87K | $11.21M | 0.79% | Add | |
| 40 |
|
106.69K | $11.08M | 0.78% | Add | |
| 41 |
|
31.05K | $11.00M | 0.78% | Hold | |
| 42 |
|
86.51K | $10.65M | 0.75% | Reduce | |
| 43 |
|
63.67K | $10.55M | 0.75% | Reduce | |
| 44 |
|
10.75K | $10.34M | 0.73% | Reduce | |
| 45 |
|
59.59K | $10.12M | 0.72% | New | |
| 46 |
|
77.97K | $10.02M | 0.71% | Reduce | |
| 47 |
|
113.75K | $9.98M | 0.71% | Add | |
| 48 |
|
23.82K | $9.21M | 0.65% | Add | |
| 49 |
|
41.08K | $9.06M | 0.64% | Add | |
| 50 |
|
16.88K | $8.76M | 0.62% | Reduce | |
FAQ
What did NIXON PEABODY TRUST CO buy in 2026-Q2?
In its 2026-Q2 13F filing, NIXON PEABODY TRUST CO reported 175 equity positions worth $1.41B in aggregate; its largest disclosed positions were IDEV ($98.53M), AVLV ($93.47M), NVDA ($70.56M).
How large is NIXON PEABODY TRUST CO's portfolio?
NIXON PEABODY TRUST CO reported $1.41B of long equity holdings across 175 positions as of 2026-Q2. Top-10 holdings account for 44.0% of reported value.
What is NIXON PEABODY TRUST CO's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.